ZimVie Inc Ordinary Shares ZIMV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZIMV is a good fit for your portfolio.
News
-
ZimVie to Participate in Upcoming Investor Conferences
-
ZimVie Reports First Quarter 2024 Financial Results
-
ZimVie to Report First Quarter Financial Results on May 8, 2024
-
ZimVie Announces Closing of Sale of Spine Business
-
ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Trading Information
- Previous Close Price
- $16.55
- Day Range
- $16.53–17.07
- 52-Week Range
- $6.52–20.91
- Bid/Ask
- $15.57 / $17.43
- Market Cap
- $454.36 Mil
- Volume/Avg
- 164,910 / 312,204
Key Statistics
- Price/Earnings (Normalized)
- 18.88
- Price/Sales
- 0.81
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 2,600
- Website
- https://www.zimvie.com
Comparables
Valuation
Metric
|
ZIMV
|
MMSI
|
SIBN
|
---|---|---|---|
Price/Earnings (Normalized) | 18.88 | 25.84 | — |
Price/Book Value | 1.17 | 3.80 | 3.49 |
Price/Sales | 0.81 | 3.70 | 3.89 |
Price/Cash Flow | 18.54 | 20.78 | — |
Price/Earnings
ZIMV
MMSI
SIBN
Financial Strength
Metric
|
ZIMV
|
MMSI
|
SIBN
|
---|---|---|---|
Quick Ratio | 0.84 | 4.22 | 8.63 |
Current Ratio | 2.78 | 6.03 | 9.76 |
Interest Coverage | −1.51 | 6.17 | −13.62 |
Quick Ratio
ZIMV
MMSI
SIBN
Profitability
Metric
|
ZIMV
|
MMSI
|
SIBN
|
---|---|---|---|
Return on Assets (Normalized) | 14.12% | 9.17% | −7.83% |
Return on Equity (Normalized) | 31.63% | 15.14% | −10.72% |
Return on Invested Capital (Normalized) | 18.79% | 10.93% | −10.92% |
Return on Assets
ZIMV
MMSI
SIBN
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Tmktxmsp | Fvwmct | $177.8 Bil | |
SYK
| Stryker Corp | Qstbrxzjxr | Gyws | $127.8 Bil | |
BSX
| Boston Scientific Corp | Mdpcwkz | Cdccd | $110.3 Bil | |
MDT
| Medtronic PLC | Dqvydwl | Jdbsccm | $105.7 Bil | |
EW
| Edwards Lifesciences Corp | Zcrjmvtnsl | Spqwt | $52.4 Bil | |
DXCM
| DexCom Inc | Qcyrjpjlr | Dcb | $50.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Wsggdjnc | Rdkqyr | $25.6 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Sprcrtmpc | Cywh | $23.7 Bil | |
STE
| Steris PLC | Mpnyxsrf | Svfmx | $22.0 Bil | |
ALGN
| Align Technology Inc | Wppqwlpl | Zpmrgn | $19.4 Bil |